Treatment with prostaglandin E1 in a porcine model of early adult respiratory distress syndrome.
The effects of treatment with PGE1 were evaluated in a porcine model of early adult respiratory distress syndrome induced by endotoxaemia. Spontaneously breathing pigs under ketamine anaesthesia were infused i.v. with E. coli endotoxin (10 micrograms X kg-1 X h-1) for 6 h. Thirteen pigs were given endotoxin, and 11 pigs were treated with a continuous infusion of PGE1, 0.25 microgram X kg-1 X min-1 for 4 h, beginning 2 h after start of endotoxin and established lung injury. Four pigs served as controls and receiving only PGE1 (0.25 microgram X kg-1 X min-1) during the whole observation period of 6 h. PGE1 treatment did not influence the decline in platelet and polymorphonuclear cell counts, whereas it markedly decreased the pulmonary hypertension induced by endotoxaemia. The increased extravascular lung water returned towards baseline after institution of PGE1. The increased venous admixture was not significantly influenced by PGE1. Treatment with PGE1 induced an exacerbated hypotensive state in the endotoxaemic animals primarily due to vasodilation. The decline in cardiac output and oxygen delivery noted in endotoxaemic pigs were not influenced by PGE1 and survival was not improved. Although one should be extremely careful in extrapolating these data to the clinical situation the results from the present study suggest the need for optimum volume replacement when starting PGE1 infusion in endotoxin-induced ARDS.
D000527:Alprostadil / Q000627:therapeutic use*; D000818:Animals; D001772:Blood Cell Count; D004731:Endotoxins / Q000097:blood; D004926:Escherichia coli; D005260:Female; D006439:Hemodynamics; D008297:Male; D010100:Oxygen / Q000502:physiology; D010313:Partial Pressure; D012128:Respiratory Distress Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D013552:Swine
D004731:Endotoxins; D000527:Alprostadil; D010100:Oxygen